| Literature DB >> 31139654 |
Zhaoyan Li1,2,3, Lei Zhong1,3, Zhenwu Du1,2,3, Gaoyang Chen1,2,3, Jing Shang1,3, Qiwei Yang2,3, Qingyu Wang1,2,3, Yang Song1,3, Guizhen Zhang1,2,3.
Abstract
BACKGROUND: Osteoarthritis (OA) is the most common degenerative disease in orthopedics. However, the cause and underlying molecular mechanisms are not clear. This study aims to identify the hub genes and pathways involved in the occurrence of osteoarthritis.Entities:
Mesh:
Year: 2019 PMID: 31139654 PMCID: PMC6500622 DOI: 10.1155/2019/8340573
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
The primers of top 10 hub genes.
| Gene | Forward primer | Reverse primer |
|---|---|---|
| GAPDH | CGGACCAATACGACCAAATCCG | AGCCACATCGCTCAGACACC |
| IL8 | ACTGAGAGTGATTGAGAGTGGAC | AACCCTCTGCACCCAGTTTTC |
| Il6 | TCAATATTAGAGTCTCAACCCCCA | GAAGGCGCTTGTGGAGAAGG |
| ADIPOQ | GCTGGGAGCTGTTCTACTG | TACTCCGGTTTCACCGATGTC |
| CXCR1 | CTGACCCAGAAGCGTCACTTG | CCAGGACCTCATAGCAAACTG |
| CXCL1 | AACCGAAGTCATAGCCACAC | GTTGGATTTGTCACTGTTCAGC |
| LIPE | TCAGTGTCTAGGTCAGACTGG | AGGCTTCTGTTGGGTATTGGA |
| SLC2A4 | TGGGCGGCATGATTTCCTC | GCCAGGACATTGTTGACCAG |
| FASN | AAGGACCTGTCTAGGTTTGATGC | TGGCTTCATAGGTGACTTCCA |
| FABP4 | ACTGGGCCAGGAATTTGACG | CTCGTGGAAGTGACGCCTT |
| FPR1 | TGGGAGGACATTGGCCTTTC | GGATGCAGGACGCAAACAC |
Figure 1Gene expression before and after normalization: The green box plots represent the data before normalization, and the red box plots represent the normalized data.
The significantly enriched analysis of DEGs in osteoarthritis.
| Expression | Category | Term | Description | Gene Count | P Value |
|---|---|---|---|---|---|
| UP-DEGs | BP | GO:0006954 | inflammatory response | 19 | 1.21E-13 |
| BP | GO:0007267 | cell-cell signaling | 11 | 3.03E-07 | |
| BP | GO:0070098 | chemokine-mediated signaling pathway | 6 | 2.07E-05 | |
| BP | GO:0006935 | chemotaxis | 7 | 2.34E-05 | |
| BP | GO:0006955 | immune response | 11 | 2.71E-05 | |
| CC | GO:0005615 | extracellular space | 25 | 1.66E-09 | |
| CC | GO:0005576 | extracellular region | 27 | 2.28E-09 | |
| CC | GO:0005578 | proteinaceous extracellular matrix | 6 | 0.006499621 | |
| CC | GO:0016323 | basolateral plasma membrane | 4 | 0.044790466 | |
| CC | GO:0031988 | membrane-bounded vesicle | 2 | 0.05975494 | |
| MF | GO:0008009 | chemokine activity | 5 | 6.54E-05 | |
| MF | GO:0045236 | CXCR chemokine receptor binding | 3 | 6.87E-04 | |
| MF | GO:0050786 | RAGE receptor binding | 3 | 0.001043791 | |
| MF | GO:0005540 | hyaluronic acid binding | 3 | 0.004638666 | |
| MF | GO:0005125 | cytokine activity | 5 | 0.007811921 | |
|
| |||||
| DOWN-DEGs | BP | GO:0006629 | lipid metabolic process | 5 | 0.001123386 |
| BP | GO:0050873 | brown fat cell differentiation | 3 | 0.003912643 | |
| BP | GO:0010890 | positive regulation of sequestering of triglyceride | 2 | 0.020252031 | |
| BP | GO:0010642 | negative regulation of platelet-derived | 2 | 0.020252031 | |
| growth factor receptor signaling pathway | |||||
| BP | GO:0042593 | glucose homeostasis | 3 | 0.035075126 | |
| CC | GO:0005811 | lipid particle | 7 | 6.93E-08 | |
| CC | GO:0005739 | mitochondrion | 11 | 0.009807547 | |
| CC | GO:0070062 | extracellular exosome | 16 | 0.031369825 | |
| CC | GO:0005576 | extracellular region | 11 | 0.032718894 | |
| CC | GO:0005615 | extracellular space | 9 | 0.067564494 | |
| MF | GO:0042803 | protein homodimerization activity | 7 | 0.016759119 | |
| MF | GO:0008144 | drug binding | 3 | 0.01974095 | |
Figure 2The top ten GO terms in each group: The top ten GO terms in each group were ranked by p value. The gradual color represents the z-score.
Figure 3GO enrichment analysis of DEGs: The gradual color represents the logFC. The genes were ordered according to their logFC values setting gene.
Figure 4KEGG enrichment analysis of the pathways: The gradual color represents the P value, the size of the black spots represents the gene number.
Signaling pathway enrichment analysis of DEGs function in osteoarthritis.
| Expression | Term | Description | Gene Count | P Value |
|---|---|---|---|---|
| DOWN-DEGs | hsa04923 | Regulation of lipolysis in adipocytes | 4 | 7.05E-04 |
| hsa03320 | PPAR signaling pathway | 4 | 0.001191375 | |
| hsa04152 | AMPK signaling pathway | 4 | 0.006702552 | |
| hsa04910 | Insulin signaling pathway | 3 | 0.07107271 | |
|
| ||||
| UP-DEGs | hsa04060 | Cytokine-cytokine receptor interaction | 8 | 1.22E-04 |
| hsa04062 | Chemokine signaling pathway | 6 | 0.001756326 | |
| hsa05202 | Transcriptional misregulation in cancer | 5 | 0.007918451 | |
| hsa05323 | Rheumatoid arthritis | 4 | 0.008366703 | |
| hsa04668 | TNF signaling pathway | 4 | 0.014229192 | |
| hsa05322 | Systemic lupus erythematosus | 4 | 0.02575911 | |
| hsa05150 | Staphylococcus aureus infection | 3 | 0.027341561 | |
Figure 5PPI network of DEGs: Red circles represent upregulated DEGs, and blue squares represent downregulated DEGs. The size of the nodes represents the degree value.
Figure 6PPI network of hub genes: The gradual color represents the degree value. The circles represent upregulated genes, and squares represent downregulated genes.
Figure 7Validation of the top 10 hub genes by qRT-PCR between the OA group and the control group: All samples were normalized to GAPDH. And the relative expression levels of each gene were calculated using 2−ΔΔCt methods. ∗ represents P <0.05.